Where We've Been and Where We're Going: A Review of 2011 and Preview of 2012 -- Improving Patient Outcomes in Skin Cancer
| Title: | Where We've Been and Where We're Going: A Review of 2011 and Preview of 2012 -- Improving Patient Outcomes in Skin Cancer |
| Topic: | Oncology/ Hematology |
| Relevant Terms: | Melanoma, Patient Outcomes, Skin Cancer |
| Primary Audience: | Dermatologic Oncologists, Dermatologists, Oncologists, Surgical Oncologists |
| Launch Date: | 21-Jan-12 |
| Credits: | 0.75 AMA PRA Category 1 Credit™ |
| Expiration Date: | 21-Jan-13 |
Learning Objectives
After completing this activity, the participant will demonstrate the ability to:
- Analyze the clinical importance of data presented in 2011 at major medical congresses and/or published in leading peer-reviewed journals focused on melanoma and nonmelanoma skin cancer to determine applicability to your individual patients
- Examine the potential impact for your individual patients of melanoma and nonmelanoma skin cancer data from at least 2 late-stage clinical trials expected to be presented in 2012
Faculty
Jennifer L. Defazio, MD
Assistant Clinical Member
Memorial Sloan-Kettering Cancer Center
New York, NY
John M. Kirkwood, MD
Usher Professor of Medicine and Dermatology
Vice Chairman for Clinical Research
Department of Medicine University of Pittsburgh Cancer Institute
Pittsburgh, PA
Assistant Clinical Member
Memorial Sloan-Kettering Cancer Center
New York, NY
John M. Kirkwood, MDUsher Professor of Medicine and Dermatology
Vice Chairman for Clinical Research
Department of Medicine University of Pittsburgh Cancer Institute
Pittsburgh, PA
INSTRUCTIONS FOR OBTAINING CME CREDIT
There are no fees or prerequisites for participating in and receiving CME credit for this online educational activity. In order to obtain CME credit for participating in this activity during the period of January 21, 2012, through January 21, 2013, participants must (1) read the educational objectives and disclosure statements; (2) participate in the educational activity; (3) complete the online learning assessment, scoring 65% or higher; (4) complete the evaluation; and (5) submit the evaluation form online.
A statement of credit will be issued only upon completion of a post-test with a score of 65% or higher and a completed activity evaluation. After submitting these forms, you will be able to print out your CME certificate.
Accreditation Statement
There are no fees or prerequisites for participating in and receiving CME credit for this online educational activity. In order to obtain CME credit for participating in this activity during the period of January 21, 2012, through January 21, 2013, participants must (1) read the educational objectives and disclosure statements; (2) participate in the educational activity; (3) complete the online learning assessment, scoring 65% or higher; (4) complete the evaluation; and (5) submit the evaluation form online.
A statement of credit will be issued only upon completion of a post-test with a score of 65% or higher and a completed activity evaluation. After submitting these forms, you will be able to print out your CME certificate.
Accreditation Statement
The Institute for Continuing Healthcare Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Institute for Continuing Healthcare Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure
It is the policy of the Institute for Continuing Healthcare Education (the Institute) that the education presented within Institute-provided, CME-certified activities be unbiased and based upon scientific evidence. To help participants make judgments about the presence of bias, the Institute provides information that planners, teachers, authors, developers, and activity managers have disclosed about financial relationships they have with commercial entities that produce or market products or services related to the content of this educational activity. Any relationships that an individual may have with commercial entities have been disclosed and reviewed, and any potential conflicts have been resolved.
Relationships are abbreviated as follows: E, Educational Planning Committee; G, Grant/research support recipient; A, Advisor/review panel member/educational planning committee; C, Consultant/Independent Contractor; S, Stock shareholder; SB, Speaker bureau; PE, Promotional Event Talks; H, Honoraria; O, Other.
Educational Planning Committee
Jennifer L. DeFazio, MD, has disclosed that she has no relevant financial relationships that have occurred within the past 12 months.
John M. Kirkwood, MD, has disclosed the following relevant financial relationships that have occurred within the past 12 months: Merck & Co./A, SB; Morphotek, Inc, GlaxoSmithKline/A.
Anne Jacobson, CCMEP, MPH, Medical Writer, has disclosed that she has no relevant financial relationships that have occurred within the past 12 months.
Content Peer Reviewer
Patricia LoRusso, DO, has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content included in this educational activity.
Activity Development Team
Patricia LoRusso, DO, has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content included in this educational activity.
Activity Development Team
Cathy Pagano, CCMEP; Sandra Davidson; Christine M. O'Leary, PharmD, BCPS, CCMEP; Karen J. Thomas, CCMEP; Scott Kober, CCMEP; April Reynolds, MS, ELS; Courtney Cohen; and Tina Chiu, MEd; are employees of the Institute and are collectively responsible for the planning, development, and management of this CME activity. These individuals have disclosed that they have had no relevant financial relationship specific to the subject matter of this activity that have occurred within the past 12 months.
Product Disclosure
Product Disclosure
This educational activity includes discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
Commercial Support
Supported by an educational grant from Genentech.
COURSE VIEWING REQUIREMENTS
|
PC
Internet Explorer (v6 or greater), or Firefox |
MAC
Safari |
For additional technical support, please send an email to tchiu@iche.edu
General Disclosure and Copyright
The opinions expressed in this educational activity are those of the participating faculty and not those of the Institute for Continuing Healthcare Education, Genentech, or any manufacturers of products mentioned herein.
The information is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a healthcare professional relative to diagnostic and treatment options of a specific patient's medical condition. In no event will the Institute for Continuing Healthcare Education be responsible for any decision made or action taken based upon the information provided through this activity.
Participants are encouraged to consult the package insert for all products for updated information and changes regarding indications, dosage, and contraindications. This recommendation is particularly important with new or infrequently used products.
Copyright 2012, Institute for Continuing Healthcare Education. All rights reserved. No part of this presentation may be reproduced or transmitted in any other form or by any means, electronic or mechanical, without first obtaining written permission from the Institute.
The Institute reserves the right to cancel or modify the activity content, faculty, and activities if necessary.
